Evaluation of dextromethorphan and dextrorphan as a preventive treatment of soman toxicity in mice

Neuroscience Letters

Volumn 234, Issue 2-3, 1997, Pages 91-94

  Dematteis, Maurice ^a,b   Mallaret, Michel ^a   Baubichon, Dominique ^b   Pernot Marino, Irmine ^b   Lallement, Guy ^b  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b CENTRE DE RECHERCHES   (France)

Author keywords

Anticonvulsant; Convulsion; Dextromethorphan; Dextrorphan; Neuroprotection; Soman

Indexed keywords

DEXTROMETHORPHAN; DEXTRORPHAN; SOMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATAXIA; CONTROLLED STUDY; CONVULSION; FASCICULATION; INTOXICATION; LEARNING; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY DISTRESS;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTICONVULSANTS; ANTITUSSIVE AGENTS; DEXTROMETHORPHAN; DEXTRORPHAN; DRUG EVALUATION, PRECLINICAL; EVALUATION STUDIES; MICE; NEUROPROTECTIVE AGENTS; SOMAN;

EID: 0030774371     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00682-4     Document Type: Article

References (21)

1. Benavides J., Capdeville C., Dauphin F., Dubois A., Duverger D., Fage D., Gotti B., McKenzie E.T., Scatton B. The quantification of brain lesions with an ω3 site ligand: a critical analysis of models of cerebral ischaemia and neurodegeneration. Brain Res. 522:1990;275-289.
2. Carpentier P., Foquin-Tarricone A., Bodjarian N., Rondouin G., Lerner-Natoli M., Kamenka J.M., Blanchet G., Denoyer M., Lallement G. Anticonvulsant and antilethal effects of the phencyclidine derivative TCP in soman poisoning. Neurotoxicology. 15:1994;837-852.
3. Harris L.W., Talbot B.G., Lennox W.J., Anderson D.R., Solana R.P. Physostigmine (alone and together with adjunct) pretreatment against soman, sarin, tabun and vx intoxication. Drug Chem. Toxicol. 14:1991;265-281.
4. Junien J.L., Leonard B.E. Drugs acting on sigma and phencyclidine receptors: a review of their nature, function and possible therapeutic importance. Clin. Neuropharmacol. 12:1989;353-374.
5. Lallement G., Carpentier P., Collet A., Baubichon D., Pernot-Marino I., Blanchet G. Extracellular acetylcholine changes in rat limbic structures during soman-induced seizures. Neurotoxicology. 13:1992;557-568.
6. Lallement G., Carpentier P., Collet A., Pernot-Marino I., Baubichon D., Blanchet G. Effects of soman-induced seizures on different extracellular amino-acid levels and on glutamate uptake in rat hippocampus. Brain Res. 563:1991;234-240.
7. Lallement G., Clarençon D., Brochier G., Baubichon D., Galonnier M., Blanchet G., Mestries J.C. Efficacy of atropine/pralidoxime/diazepam or atropine/HI-6/prodiazepam in primates intoxicated by soman. Pharmacol. Biochem. Behav. 56:1997;325-332.
8. Lallement G., Delamanche I.S., Pernot-Marino I., Baubichon D., Denoyer M., Carpentier P., Blanchet G. Neuroprotective activity of glutamate receptor antagonists against soman-induced hippocampal damage: quantification with an ω3 site ligand. Brain Res. 618:1993;227-237.
9. McDonough J.H. Jr., Jaax N.K., Crowley R.A., Mays M.Z., Modrow H.E. Atropine and/or diazepam therapy protects against soman-induced neural and cardiac pathology. Fundam. Appl. Toxicol. 13:1989;256-276.
10. Mc Leod C.G. Jr., Singer A.W., Harrington D.G. Acute neuropathology in soman poisoned rats. Neurotoxicology. 5:1984;53-57.
11. Moreau J.L., Pieri L., Prud'hon B. Convulsions induced by centrally administered NMDA in mice: effects of NMDA antagonists, benzodiazepines, minor tranquilizers and anticonvulsants. Br. J. Pharmacol. 98:1989;1050-1054.
12. 3H]dextrorphan recognition site of the NMDA-operated cation channel mediates the anticonvulsant actions of dextrorotatory opioids and phencyclidine. In J.M. Kamenka and E.F. Domino (Eds.), Multiple Sigma and PCP Receptor Ligands: Mechanisms for Neuromodulation and Neuroprotection?, NPP Books, Ann Arbor, MI, 1992, pp. 695-713.
13. Schmitt B., Netzer R., Fanconi S., Baumann P., Boltshauser E. Drug refractory epilepsy in brain damage: effect of dextromethorphan on EEG in four patients. J. Neurol. Neurosurg. Psychiatry. 57:1994;333-339.
14. Schneider S.M., Michelson E.A., Boucek C.D., Ilkhnanipour K. Dextromethorphan poisoning reversed by naloxone. Am. J. Emerg. Med. 9:1991;237-238.
15. Shih T.M., Koviak T.A., Capacio B.R. Anticonvulsants for poisoning by the organophosphorous compound soman: pharmacological mechanisms. Neurosci. Biobehav. Rev. 15:1991;349-362.
16. Sparenborg S., Brennecke L.H., Braitman D.J. Prevention of soman neurotoxicity by non-opioid antitussives. Neurotoxicology. 11:1990;509-520.
17. Sparenborg S., Brennecke L.H., Jaax N.K., Braitman D.J. Dizocilpine (MK-801) arrests status epilepticus and prevents brain damage induced by soman. Neuropharmacology. 4:1992;357-368.
18. Tortella F.C., Pellicano M., Bowery N.G. Dextromethorphan and neuromodulation: old drug coughs up new activities. Trends Pharmacol. Sci. 10:1989;501-507.
19. Trube G., Netzer R. Dextromethorphan: cellular effects reducing neuronal hyperactivity. Epilepsia. 35(Suppl. 5):1994;62-67.
20. Wong B.Y., Coulter D.A., Choi D.W., Prince D.A. Dextrorphan and dextromethorphan, common antitussives, are antiepileptic and antagonize N-methyl-D-aspartate in brain slices. Neurosci. Lett. 85:1988;261-266.
21. Wu D., Otton S.V., Kalow W., Sellers E.M. Effects of route of administration on dextromethorphan pharmacokinetics and behavioral response in the rat. J. Pharmacol. Exp. Ther. 274:1995;1431-1437.